ArticleBMC musculoskeletal disorders2025
Patient reported outcomes during the first month following anterior and posterior total hip arthroplasty and hip resurfacing.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurgical treatment for osteoarthritis of the hip includes hip resurfacing (HR) and total hip arthroplasty (THA) via various surgical approaches. The discussion about the benefits and preferability of each procedure is highly controversial. We aimed to quantify the patients' utilization of opioids within the first 30 days following surgery and hypothesized that there are no differences in pain, medication, ability to walk, and function between direct anterior approach THA (DAA-THA), posterior approach THA (PA-THA), and HR.
methodsThis retrospective study evaluated 207 hips in 199 patients (DAA: 126 hips, PA: 59, HR: 21), who underwent surgery for primary osteoarthritis between 2020 and 2022. Patients used an app (SeamlessMD, Toronto, Canada) to report pain, utilization of opioids, additional pain medication, walking distance, swelling, and wound drainage for 30 days and HOOS-JR and satisfaction at one month after surgery. Results were compared between the groups after adjusting for age and BMI and patient satisfaction was correlated with pain and function.
resultsOpioid cessation was 99% 20 days after surgery. HOOS-JR improvement from pre- to postoperative was 23 points on average (-29-82, SD 15) and was significant in all groups (p < 0.001). No differences in pain, the dosage of opioids and complications were found between DAA-THA, PA-THA and HR.
conclusionThe current data showed a high rate of opioid cessation (99%) within 3 weeks following hip reconstructive surgery. DAA-THA, PA-THA, and HR provided comparable opioid usage, function, and a low early complication rate within the first month after surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.